Thanks to groups like the Premier healthcare alliance, federal officials have been kept informed of one of the worst drug shortages impacting U.S. hospitals in recent history. Patient care is ...
"A reasonable juror could find that the defendants’ 'blaming supply,' making uncompetitively high bids and falsely citing ...
Millions of Americans who rely on popular weight-loss and diabetes medications such as Zepbound and Wegovy will soon see ...
Buyout bosses intend to contest any attempt by competition watchdog to disqualify them as directors of British companies ...
The pharmaceutical company Amgen is suing the Colorado Prescription Drug Affordability Board after the price of one of its ...
President Donald Trump announced a landmark agreement Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to ...
Attorney General Dana Nessel’s ability to go after a major producer of insulin for price gouging was before the Michigan ...
Plus, how a little-known Utah lender became First Brands’ biggest creditor and Novo Nordisk gatecrashes Pfizer’s latest deal ...
Groups welcome reversal of Gilead’s price gouging decision that would have resulted in fewer people with HIV getting access to lifesaving treatment. Last week, following months of negotiations between ...
The Financial Times covers significant financial stories. EQT considers acquiring German marketplace Mobile.de. Delaware's attorney-general warns OpenAI over public interest. Aquarian Holdings ...
A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback